Quick Overview: Jurjen Versluis, MD, PhD, Erasmus MC Cancer Institute, Rotterdam, Netherlands, discusses progression-free survival (PFS) as an ... Bradley Monk, MD, gynecologic oncologist, University of Arizona Cancer Center Phoenix Branch, discusses clinical trial Device Development Luncheon: From Funding to Freedom to Operate.
Dr Markman On Endpoints In - Detailed Overview & Context
Jurjen Versluis, MD, PhD, Erasmus MC Cancer Institute, Rotterdam, Netherlands, discusses progression-free survival (PFS) as an ... Bradley Monk, MD, gynecologic oncologist, University of Arizona Cancer Center Phoenix Branch, discusses clinical trial Device Development Luncheon: From Funding to Freedom to Operate. Despite the prevalence of antihypertensive therapies and widespread awareness campaigns, half of the US population has ... Carol Aghajanian, MD, from the Memorial Sloan-Kettering Cancer Center, discusses the difficulties with a gold standard clinical ... More Endoscopic Spine Surgery From ERAS to ...
Peter Hillmen, MBChB, PhD, FRCP, FRCPath, from Leeds Teaching Hospital NHS Trust, Leeds, UK, provides an insight into the ...
